Phase II study of multiple LXH254 drug combinations in patients (pts) with unresectable/metastatic, BRAF V600-or NRAS-mutant melanoma Meeting Abstract
| Authors: | Lebbe, C.; Long, G. V.; Robert, C.; Hamid, O.; Atkinson, V. G.; Shoushtari, A. N.; Daud, A.; Bechter, O. E.; Schadendorf, D.; Sullivan, R. J.; Dummer, R.; Grob, J. J.; Lewis, N.; Fan, L.; Basu, S.; Caponigro, G.; Cooke, V. G.; Lau, A.; Amaria, R. |
| Abstract Title: | Phase II study of multiple LXH254 drug combinations in patients (pts) with unresectable/metastatic, BRAF V600-or NRAS-mutant melanoma |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1407 |
| Language: | English |
| ACCESSION: | WOS:000866211602448 |
| DOI: | 10.1016/j.annonc.2022.08.038 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA40 -- Source: Wos |
